The Beijing-Tianjin-Hebei (BTH) region is severely polluted by ozone (O). Accurate O estimates are essential for identifying high-polluted zones and developing targeted interventions to relieve the burden of diseases. Although many studies have estimated high-resolution O concentrations in BTH, the estimation accuracies are still insufficient. In this study, we incorporated data-driven spatial weight matrices (DDWs) into a random forest (RF) model to fully utilize both the spatial homogeneity and heterogeneity of maximum daily 8-h ozone concentration (MDA8O), and obtained full-coverage MDA8O concentrations at 1 km×1 km in BTH from 2014 to 2022. DDW-RF exhibited satisfactory accuracy (10-fold cross-validation R =0.937, RMSE=13.919 μg/m). Overall O level presented a spatial pattern of lower in the north and higher in the southeast and showed a distinct temporal trend, i.e., first increasing and then decreasing during 2014-2021 and increasing slightly in 2022. The accurate MDA8O estimates indicates that more attention and resources should be poured into the areas adjacent to Bohai Rim, Shandong and Henan. Regulated operation of factories under specific meteorological conditions and upgrading industrial structure and production modes are recommended to mitigate the formation of O precursors and reduce O generation. Our findings provide evidence and reference for environmental cleaning policies and targeted interventions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jhazmat.2024.136047 | DOI Listing |
Alzheimers Dement
December 2024
Mallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Background: Alzheimer's Disease can present with heterogenous neurodegenerative patterns. In order to optimize clinical trials and personalized medicine, the identification and characterization of diverse pathological brain patterns associated with AD have become paramount. Optimal approaches to identify such heterogeneity are unknown.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Background: The variability in the regional distribution of Aβ-PET signal and its relation to clinical features is debated. We used data-driven approaches to uncover heterogeneity in cortical Aβ-PET signal from a large representative sample collected through the IDEAS study.
Methods: We analysed cross-sectional Aβ-PET collected from 10,361 patients with MCI or mild dementia scanned in 295 PET facilities using one of the 3 FDA-approved tracers.
Alzheimers Dement
December 2024
McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.
Background: Alzheimer's disease is a neurodegenerative disease associated with the accumulation of Amyloid-β and Tau neurofibrillary tangles following a pattern known as Thal and Braak stages, respectively (Thal 2002; Braak 1995,2011). Recent research (Pascoal 2020) showed the possibility of recapitulating Braak's histopathological stages in vivo using PET tracer [F]-MK-6240 with manually defined regions of interest. This study analyzes the joint patterns of Amyloid-β and Tau accumulation associated with AD in a completely data-driven fashion.
View Article and Find Full Text PDFBackground: Positron emission tomography (PET) can facilitate precise spatial and temporal measurement of Alzheimer's disease pathology in the brain. The default quantification measure is the standardized uptake value ratio (SUVR) of radiotracer uptake in a target region of interest normalised by uptake in a reference region. Evaluations of new radiotracers commonly assess test-retest consistency in scans with no pathological changes, but rarely question the SUVR paradigm.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
Background: The variability in the regional distribution of Aß-PET signal and its relation to clinical features is debated. We used data-driven approaches to uncover heterogeneity in cortical Aß-PET signal from a large representative sample collected through the IDEAS study.
Methods: We analysed cross-sectional Aß-PET collected from 10,361 patients with MCI or mild dementia scanned in 295 PET facilities using one of the 3 FDA-approved tracers.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!